Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
385.73
+7.37 (1.95%)
At close: Jul 28, 2026, 4:00 PM EDT
385.50
-0.23 (-0.06%)
After-hours: Jul 28, 2026, 7:39 PM EDT

Elevance Health Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Equivalents
10,2329,6579,4918,7138,5607,5008,2887,8666,4976,2266,52610,9199,99110,1427,3878,8726,4566,1614,8805,490
Short-Term Investments
27,28227,41626,62427,50326,23226,15226,39330,06729,49430,04129,84327,97628,29328,02826,90527,02927,33727,88128,14828,467
Cash & Short-Term Investments
37,51437,07336,11536,21634,79233,65234,68137,93335,99136,26736,36938,89538,28438,17034,29235,90133,79334,04233,02833,957
Cash Growth (YoY)
7.82%10.17%4.13%-4.53%-3.33%-7.21%-4.64%-2.47%-5.99%-4.99%6.06%8.34%13.29%12.13%3.83%5.73%2.86%-9.25%7.47%14.08%
Accounts Receivable
16,57416,62315,23514,65715,91915,60513,05512,34413,33713,17312,46011,63911,32712,03211,74610,55510,60111,3289,6919,357
Other Receivables
6,8186,1676,3077,6927,2066,5766,0166,0555,8815,1205,4055,2935,1964,6784,2983,6513,6003,3343,7493,450
Total Trade Receivables
23,39222,79021,54222,34923,12522,18119,07118,39919,21818,29317,86516,93216,52316,71016,04414,20614,20114,66213,44012,807
Other Current Assets
6,2787,1695,3445,2135,4075,2885,1906,5147,0656,3885,7955,3584,9364,9435,2815,4965,6615,1934,6545,140
Total Current Assets
67,18467,03263,00163,77863,32461,12158,94262,84662,27460,94860,02961,18559,74359,82355,61755,60353,65553,89751,12251,904
Net Property, Plant & Equipment
4,6454,6574,6794,6574,6414,6174,6524,5054,4504,4514,3594,2484,5474,4184,3164,1974,0903,9863,9193,835
Other Intangible Assets
10,98311,09311,20011,32711,49011,94012,09410,32510,44710,71010,27310,49110,70310,91510,31510,53610,76210,58810,61510,749
Goodwill
28,33928,34028,34428,45128,36828,42028,27725,96725,96225,94725,31725,29125,27425,27324,38324,38124,36724,25124,22824,184
Long-Term Investments
12,38912,12311,96011,75911,55311,22710,78410,2877,6597,5936,9836,9346,7686,7546,4376,1386,0015,9615,8575,584
Other Long-Term Assets
2,8982,5822,3102,7772,5622,3922,1402,6032,1962,2451,9672,3292,1331,8571,6872,1712,0021,8031,7191,804
Total Assets
126,438125,827121,494122,749121,938119,717116,889116,533112,988111,894108,928110,478109,168109,040102,755103,026100,877100,48697,46098,060
Accounts Payable
6,6326,2097,3226,0857,2787,1316,9276,2555,7605,6586,9105,9835,0334,8735,6074,9635,8505,4934,9705,960
Short-Term Debt
-7241501803602503653602251,575225-265265265265175275275175
Current Portion of Long-Term Debt
3753501,0997491,6481,6431,6492,1002,9002,9001,649799--1,5002,2492,2483,0971,599849
Unearned Revenue
1,6401,7591,4931,8311,5611,6401,5081,7931,4811,4741,4024,3324,4584,3941,1123,7029711,2101,153954
Other Current Liabilities
35,60736,26730,97132,03332,98732,03430,13231,52531,44732,72731,60532,22331,81532,35731,21230,10830,06429,65826,88827,224
Total Current Liabilities
44,25445,30941,03540,87843,83442,69840,58142,03341,81344,33441,79143,33741,57141,88939,69641,28739,30839,73334,88535,162
Long-Term Debt
30,66930,76830,79731,17328,17828,11029,21824,68824,56121,97623,24624,04524,85925,20122,34921,25821,16519,88321,15721,761
Other Long-Term Liabilities
6,4935,7085,6366,6166,0756,2895,6645,9334,3174,8744,4864,5574,4264,4904,3804,4384,5374,8395,2905,329
Total Long-Term Liabilities
37,16236,47636,43337,78934,25334,39934,88230,62128,87826,85027,73228,60229,28529,69126,72925,69625,70224,72226,44727,090
Total Liabilities
81,41681,78577,46878,66778,08777,09775,46372,65470,69171,18469,52371,93970,85671,58066,42566,98365,01064,45561,33262,252
Preferred Stock
----------0---------
Common Stock
22222222222222222222
Additional Paid-in Capital
8,9178,8458,9388,9088,9318,8668,9119,1059,0018,8838,8688,8308,7618,6979,0849,1699,1349,1519,1489,138
Accumulated Other Comprehensive Income
-711-741-451-543-760-911-1,147-489-1,387-1,365-1,313-2,512-2,166-2,050-2,490-2,784-2,149-1,236-178-103
Retained Earnings
36,67535,79635,39335,58635,54934,54633,54935,15734,57533,08831,74932,10331,60830,70729,64729,60428,82528,05827,08826,700
Total Common Shareholders' Equity
44,88343,90243,88243,95343,72242,50341,31543,77542,19140,60839,30638,42338,20537,35636,24335,99135,81235,97536,06035,737
Minority Interest
13914014412912911711110410610299116107104875255566871
Shareholders' Equity
45,02244,04244,02644,08243,85142,62041,42643,87942,29740,71039,40538,53938,31237,46036,33036,04335,86736,03136,12835,808
Total Liabilities & Equity
126,438125,827121,494122,749121,938119,717116,889116,533112,988111,894108,928110,478109,168109,040102,755103,026100,877100,48697,46098,060
Total Debt
31,04431,84232,04632,10230,18630,00331,23227,14827,68626,45125,12024,84425,12425,46624,11423,77223,58823,25523,03122,785
Net Cash (Debt)
6,4705,2314,0694,1144,6063,6493,44910,7858,3059,81611,24914,05113,16012,70410,17812,12910,20510,7879,99711,172
Net Cash Growth (YoY)
40.47%43.35%17.98%-61.85%-44.54%-62.83%-69.34%-23.24%-36.89%-22.73%10.52%15.85%28.96%17.77%1.81%8.57%6.18%-24.45%-6.55%25.20%
Net Cash Per Share
29.6923.7318.3418.3920.4016.0614.9246.2735.5841.9147.7159.4155.3453.0042.2050.0841.9344.1440.7245.41
Book Value
44,88343,90243,88243,95343,72242,50341,31543,77542,19140,60839,30638,42338,20537,35636,24335,99135,81235,97536,06035,737
Book Value Per Share
205.98199.19197.84196.48193.63187.07178.78187.79180.77173.39166.69162.47160.66155.84150.26148.60147.13147.20146.88145.27
Tangible Book Value
5,5614,4694,3384,1753,8642,1439447,4835,7823,9513,7162,6412,2281,1681,5451,0746831,1361,217804
Tangible Book Value Per Share
25.5220.2819.5618.6617.119.434.0832.1024.7716.8715.7611.179.374.876.414.432.814.654.963.27
SEC Filings: 10-K · 10-Q